Effect of HLA-DR matching on rejection after cardiac transplantation.
Cochrane
A
A
Centre for Heart and Lung Transplantation, Alfred Hospital, Prahran, Victoria, Australia.
Benson
E
E
Williams
T
T
Bergin
P
P
Esmore
D
D
D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000276:immunology*; D006684:HLA-DR Antigens / Q000032:analysis*; D016027:Heart Transplantation / Q000276:immunology*; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D008297:Male; D016853:Muromonab-CD3 / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D012307:Risk Factors; D012727:Sex Characteristics; D013997:Time Factors
D000961:Antilymphocyte Serum; D006684:HLA-DR Antigens; D016853:Muromonab-CD3; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine